The bill
Risky Research Review Act
S. 854, 119th Congress — read as touching Biotech & Research.
Risky Research Review Act
Download PDFBill ID: 119/s/854
Last Updated: January 20, 2026
Sponsored by
Sen. Paul, Rand [R-KY]
ID: P000603
Follow the money
The sponsor
Sen. Paul, Rand [R-KY]
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
$87,500 raised
20 itemised contributions to this sponsor, pulled from FEC filings.
The alignment
70% match to Project 2025
This bill's text tracks the "Environmental Protection Agency" section, p. 470-472 of the Mandate for Leadership.
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
September 16, 2025
Introduced
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
🏛️
Committee Review
🗳️
Floor Action
✅
Passed Senate
🏛️
House Review
🎉
Passed Congress
🖊️
Presidential Action
⚖️
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
Another masterpiece of legislative theater, courtesy of the esteemed members of Congress. The Risky Research Review Act (S 854) - a bill that promises to protect us from the dangers of dual-use research while actually serving as a Trojan horse for bureaucratic expansion and special interest pandering.
**Main Purpose & Objectives:** The bill's stated purpose is to establish the Life Sciences Research Security Board, which will supposedly review and regulate "dual use research of concern" - research that could potentially be used for nefarious purposes. But let's not be naive; this board will likely become a rubber stamp for the interests of powerful lobbies and government agencies.
**Key Provisions & Changes to Existing Law:** The bill creates a new chapter in Title 31, United States Code, establishing the Life Sciences Research Security Board. The board will have sweeping powers to review research proposals, impose regulations, and even conduct audits. But don't worry, it's all for our safety - or so they claim.
**Affected Parties & Stakeholders:** The usual suspects will benefit from this bill: government agencies seeking more power, researchers looking for funding and prestige, and lobbyists representing the interests of pharmaceutical companies and biotech firms. Meanwhile, taxpayers will foot the bill for this bureaucratic expansion, and actual research may be stifled by the added regulatory burden.
**Potential Impact & Implications:** This bill is a classic case of "mission creep." It starts with a seemingly noble goal - protecting us from dual-use research - but ultimately becomes a vehicle for government overreach and special interest influence. The board will likely become a tool for suppressing research that challenges the status quo or threatens powerful interests.
In medical terms, this bill is akin to a patient presenting with symptoms of bureaucratic bloat and regulatory fever. The diagnosis? A bad case of "Legislative-itis" - a disease characterized by an excessive growth of government agencies, fueled by special interest money and a disregard for individual liberties.
Treatment? A healthy dose of skepticism, followed by a strong prescription of transparency and accountability. But don't hold your breath; this patient is likely to remain in a state of chronic bureaucratic illness, with the Risky Research Review Act serving as just another symptom of a deeper disease - the corruption and cowardice that plagues our legislative system.
Related Topics
Research & Innovation PolicyPublic Health & Pandemic Response
Generated using Llama 3.1 70B (Dr. Haus personality)
💰 Campaign Finance Network
Sen. Paul, Rand [R-KY]
Congress 119 • 2024 Election Cycle
Total Contributions
$1,164,409
852 donors
PACs
$0
Organizations
$0
Committees
$0
Individuals
$1,164,409
No PAC contributions found
No organization contributions found
No committee contributions found
1
MACRICOSTAS, GEORGE C. MR.
$16,500
2
ANDREESSEN, LAURA ARRILLAGA
$9,900
3
ANDREESSEN, MARC
$9,900
4
GROSS, MARY E. MRS.
$9,900
5
KARVELA, ELENI
$9,900
6
MCPHEE, MICHAEL
$9,900
7
MOSSEL, JOHN W. MR
$9,600
8
TINGLE, RALPH J. MR.
$8,800
9
BORST, LAURA J. MS.
$8,706
10
ANDERSON, RICHARD N. MR.
$8,500
11
PECK, JOHN MR. JR.
$8,300
12
CEO, JOSEPH S. MR.
$8,200
13
KONNOR, DELBERT DANIEL MR. II
$7,853
14
HAYDEN, MARILYN MS
$7,000
15
COLBERT, THOMAS W. MR.
$6,700
16
DEIHL, RICHARD
$6,700
17
GONZALEZ, DIANNE
$6,700
18
LOWERY, CARLA
$6,700
19
MILBURN, ANN MS.
$6,700
20
MURPHY, JOSEPH M.
$6,700
21
FORSYTHE, GERALD R. MR.
$6,600
22
NOSEK, NICOLE
$6,300
23
RADGOWSKI, STEVEN
$6,300
24
AMTOWER, PATRICIA C.
$6,228
25
RYAN, KELSIE W. MRS.
$5,750
26
GARVER, CURTIS M.
$5,700
27
NAYAK, BHARATHI
$5,700
28
KIPILMAN, CAROL
$5,500
29
CONRADS, RANDAL MR.
$5,300
30
SMEAD, LARRY MR.
$5,300
31
ZEHRER, TERRENCE LEO MR.
$5,300
32
SPENCE, CORINNE S. MS.
$4,950
33
CLOPTON, TROY MR.
$4,700
34
FOWLER, RANDALL
$4,700
35
SHOTTS, NORMAN MR. II
$4,700
36
YODER, MAHLON DAVID MR.
$4,300
37
STONE, MARION PYLE MS.
$3,650
38
BRUGGEMAN, DANIEL
$3,500
39
CURRAN, WILLIAM E. MR. JR
$3,500
40
KOLCHINS, CHERYL
$3,500
41
BECKMAN, KURT
$3,300
42
BRUE, VANE
$3,300
43
CHARLES, DAVID
$3,300
44
COLBURN, BETSY
$3,300
45
COLE, STEPHANIE
$3,300
46
COLLINS, DENNIS
$3,300
47
COOMES, JEFFREY D. MR.
$3,300
48
CREEKMORE, JUDITH C. MS.
$3,300
49
DEARING, MICHAEL C. MR.
$3,300
50
DENICOLA, ANTHONY
$3,300
51
DEUSER, JACK S. MR. JR.
$3,300
52
DOMINGUEZ, WILLIAM
$3,300
53
DOWNIE, JULIE
$3,300
54
FAUST, ANNE MS.
$3,300
55
FISCHER, DAVID T. SR.
$3,300
56
FISHER, GEORGE
$3,300
57
FORBES, SEAN
$3,300
58
FORSYTHE, GERALD MR.
$3,300
59
GATES, RORY
$3,300
60
GORE, DAVID
$3,300
61
GRAYSON, ARTHUR MR.
$3,300
62
HALL, JAMES E. MR.
$3,300
63
HALL, SANDY MRS.
$3,300
64
HALLBERG, VICTOR MR.
$3,300
65
HAMER, JONATHAN
$3,300
66
HORNER, JULIA
$3,300
67
JARVIS, ALEIX MR.
$3,300
68
JOHN, CATHERINE
$3,300
69
LANGHORNE, WILLIAM
$3,300
70
MARTIN, JEANNE A.
$3,300
71
METNICK, JOSH MR.
$3,300
72
MURPHY, EUGENE
$3,300
73
MUSCARELLE, SHARON M. MRS.
$3,300
74
PECK JR, JOHN
$3,300
75
PRECODA, DALE
$3,300
76
PRICE, FRANCIS W. DR. JR.
$3,300
77
PRICE, KAYLEE
$3,300
78
RATHKE, MELINDA
$3,300
79
RITTER, WILLIAM LARKIN MR.
$3,300
80
ROWLEY, SANDRA MS.
$3,300
81
RUMY, ZSOLT
$3,300
82
RUSSELL, JAMES
$3,300
83
WILSON, MICHAEL
$3,300
84
BRENT, JANICE MRS.
$3,250
85
MAYER, THERESA
$3,202
86
HUNT, WAYNE
$3,100
87
BISHOP, JACK L. MR.
$3,000
88
DAVIS, LOIS
$3,000
89
GLASS, LYNNEA
$3,000
90
HEIST, ROBERT WARREN MR.
$3,000
91
HIBSHMAN, PATRICIA
$3,000
92
JAMES, THOMAS MR.
$3,000
93
PERLOW, JON MR.
$3,000
94
SHEA, RICHARD
$3,000
95
SOWARDS, GREG
$3,000
96
SPENCER, DIANA MS.
$3,000
97
WARD, EDWARD H. MR.
$3,000
98
WOMMACK, ANGELA
$3,000
99
HESS, PETER J. MR.
$3,000
100
RADY, PAUL
$3,000
101
POMS, DAVID
$2,800
102
GERMANN, JEANNETTE MS.
$2,501
103
BANKS, GEORGE
$2,500
104
BARCARDI, RUBY MS.
$2,500
105
BLANKENBAKER, TERIE MRS.
$2,500
106
CARLSON, ROBERT B. MR.
$2,500
107
GOLDSBURY, KIT
$2,500
108
HORVITZ, NORMA MS.
$2,500
109
HRUSKA, JAMES J. MR.
$2,500
110
HUDGENS, RALPH MR.
$2,500
111
JOURNAY, JUSTIN
$2,500
112
KENDALL, LINDA C. MS.
$2,500
113
KNOLL, LEROY
$2,500
114
LYONS, MARK
$2,500
115
PAULETTO, JOE B. MR. JR
$2,500
116
PUTZAN, CONRAD S. MR.
$2,500
117
SCANTLIN, MARY J.
$2,500
118
SHEA, MORTIMER P. MR.
$2,500
119
SMITH, CLARENCE E. MR.
$2,500
120
SMITH, WILLIAM B. MR.
$2,500
121
WORLEY, BRET
$2,500
122
NAYDEN, GREGORY MR.
$2,500
123
BROWN, VIRGINIA M.
$2,100
124
MACKAIG, RICHARD A. MR.
$2,080
125
SMEED, CLAIRE J. MS.
$2,050
126
BURNS, TONY
$2,020
127
ASHCRAFT, CLARENCE W. MR.
$2,000
128
BLAKE, WALTER L. MR.
$2,000
129
BURT, KELLY MR.
$2,000
130
BUTLER, MICHAEL MR.
$2,000
131
CONLEY, MARK MR.
$2,000
132
CONRADS, SHARON E.
$2,000
133
COPELAND, LAMMONT D.
$2,000
134
COPELAND, LAMMOT MR. JR.
$2,000
135
DANDREA, ARNETTA MS.
$2,000
136
DARLING, BRIAN H.
$2,000
137
DEERING, GAIL M. MS.
$2,000
138
DEGROOT, H. PAUL MR.
$2,000
139
GARVER, MIKE MR.
$2,000
140
GREEMAN, WALTER MRS.
$2,000
141
HAAHEIM, CAROLYN J. MS.
$2,000
142
HAUSER, EDWARD MR.
$2,000
143
HUNT, LINDA MRS.
$2,000
144
HUNT, STEVE MR.
$2,000
145
HUNT, WAYNE MR.
$2,000
146
IBRAHIM, GEORGE K. DR.
$2,000
147
KAHN, SANDY
$2,000
148
LANSING, GREGORY
$2,000
149
LARSON, JENNIFER LYNN MS.
$2,000
150
LOGAN, GEORGE MR.
$2,000
151
MALANAPHY, JEAN H. MRS.
$2,000
152
MIGUEL, THOMAS
$2,000
153
MURPHY, BARBARA L. MS.
$2,000
154
PALMER, JACK A. MR. JR.
$2,000
155
PARK, WILLIAM MAX
$2,000
156
PUFF, ROBERT MR. JR.
$2,000
157
RANDELL, ROBERT L. MR.
$2,000
158
REISS, CLAIRE K.T. MS.
$2,000
159
ROURKE, BRIAN
$2,000
160
SPITLER, KENNETH F. MR.
$2,000
161
SPROUSE, GARY F. MR.
$2,000
162
SUMMERSON, FAITH
$2,000
163
VALENTIN, LEONARDO
$2,000
164
WELLEHAN, DAN J. MR. JR.
$2,000
165
WILT, WILLIAM
$2,000
166
WITZKY, CHRISTOPHER MR.
$2,000
167
HUTCHENS, STEPHEN M. MR.
$1,800
168
JENSEN, ERIC C. MR.
$1,750
169
WARREN, ALETA MS.
$1,750
170
ADAMS, CAROL
$1,650
171
PETERSON, RICHARD R. MR
$1,650
172
WILLETT, WILLIAM ROSCOE MR.
$1,650
173
ROOT, MIKE MR.
$1,550
174
DUARTE, DAVID MR.
$1,501
175
BAKER, DONALD MR.
$1,500
176
BAKER, PETER F. MR.
$1,500
177
BARNES, MARGOT
$1,500
178
BELER, SAMUEL
$1,500
179
BETZ, KARL F. MR. JR.
$1,500
180
BLAND, ROBERT STEVEN MR.
$1,500
181
BLUMENSON, MICHAEL
$1,500
182
BRADLEY, ROBERT
$1,500
183
BREKKE, JERRY MR.
$1,500
184
BRENNER, DOUGLAS
$1,500
185
BRITTON, PETER P.
$1,500
186
COURTNEY, RONALD MR.
$1,500
187
DEMASTERS, BABALA K.
$1,500
188
DOBKIN, DAVID
$1,500
189
ENGSTROM, PAUL F.
$1,500
190
GARDNER, MICHAEL T. MR. SR.
$1,500
191
HARRISON, KATHERINE
$1,500
192
HOLSCLAW, RALPH J.
$1,500
193
KLOCKO, BRENDA M.
$1,500
194
LATHAM, KENNETH R. MR.
$1,500
195
LEE, RICHARD T. MR.
$1,500
196
LEWIS, EDWARD DONOVAN MR.
$1,500
197
LUNDEN, PATRICIA R. MRS.
$1,500
198
LYON, YVONNE M. MRS.
$1,500
199
MARSHALL, JOHN F. MR.
$1,500
200
MEALER, BROCK
$1,500
201
MOWRY, ELLEN
$1,500
202
MUCHMORE, JOHN W.
$1,500
203
NORSWORTHY, GEORGE
$1,500
204
PATTILLO, MARIANNE
$1,500
205
SAHAKIAN, DANIE
$1,500
206
SCHRAMM, CHARLES STEVE DR. JR.
$1,500
207
SCOTT, FRED W. MR.
$1,500
208
SIMPERMAN, ROY F. MR.
$1,500
209
SIU, MONA
$1,500
210
STIGLITZ, MARILYN MRS
$1,500
211
STONE, STUART REAGAN MR.
$1,500
212
STROH, CARLA H. MS.
$1,500
213
WILSON, RANSOM
$1,500
214
ZUMBIEL, MARY LEE MRS.
$1,500
215
STEGE, AUDRAE I.
$1,300
216
ELKINS, RONALD J. MR.
$1,250
217
BALK, JOSH
$1,200
218
MAKINSON, DONALD W. MR.
$1,200
219
ESPOSITO, MAUREEN MS.
$1,044
220
HUDDLESTON, BRANT
$1,002
221
ADKINS, DEBORAH
$1,000
222
ALFORD, JAMES H. MR
$1,000
223
ALLMAN, MICHAEL MR.
$1,000
224
ANDRESEN, KENNETH W. MR.
$1,000
225
ARKES, HAL MR.
$1,000
226
BAJUS, STEPHEN W. MR.
$1,000
227
BAKER, PAMELA
$1,000
228
BARROWS, MARVIN H.
$1,000
229
BAUMGARDNER, JOHN
$1,000
230
BENTLEY, MIGNON M.
$1,000
231
BILLS, JAMES P. MR.
$1,000
232
BLEVINS, HAROLD W. DR.
$1,000
233
BLOCK, GEORGE P. MR. JR
$1,000
234
BOGER, THOMAS
$1,000
235
BOLIN, RICHARD G.
$1,000
236
BOULLE, KAREN MRS.
$1,000
237
BOWDEN, BARBARA
$1,000
238
BOYD, DON MR.
$1,000
239
BOYD, DONALD B.
$1,000
240
BRUELLMAN, VERDA
$1,000
241
BURKE, GEM MR.
$1,000
242
BURNS, ANTONY
$1,000
243
BURNS, FRANK R. DR.
$1,000
244
CAMARA, STEVEN
$1,000
245
CARSON, DEBORAH OWEN MS.
$1,000
246
CASEY, WILLIAM
$1,000
247
CHAMBERS, RUTH
$1,000
248
CHERIPKA, KEVIN J. MR.
$1,000
249
CLARK, JAMES
$1,000
250
CLAY, ALBERT WILLIAM MR. III
$1,000
251
COHEN, GERARD MR.
$1,000
252
CONDON, JOHN W. MR.
$1,000
253
CORKEN, DONALD IRVIN
$1,000
254
COTE, CHERYL L. MRS.
$1,000
255
CRAIG, CORBIN
$1,000
256
CRAIG, MARGARET MRS.
$1,000
257
CRAWLEY, GEOFFREY W. MR.
$1,000
258
CUNNINGHAM, BRYAN
$1,000
259
CUNNINGHAM, JUTTA
$1,000
260
CUNNINGHAM, RAYMOND MR.
$1,000
261
CUSTER, VERLIN MR.
$1,000
262
DACEY, JAMES T. MR.
$1,000
263
DEGROOT, H PAUL MR.
$1,000
264
DEMPEWOLF, THOMAS MR.
$1,000
265
DOTSON, TERRY L.
$1,000
266
DROBA, AARON
$1,000
267
DRUCKMAN, MICHAEL
$1,000
268
DRUMMOND, A. CAROLINE MRS.
$1,000
269
DUGAN, PATRICK
$1,000
270
EASTON, JOHN
$1,000
271
EBE, NANCY
$1,000
272
ECKER, NEITH
$1,000
273
ELLINGSEN, PAUL D. MR.
$1,000
274
FANGMAN, BRYAN MR.
$1,000
275
FARRAR, CHRISTINE
$1,000
276
FARRELL, JOE
$1,000
277
FARRELL, PETER C. DR.
$1,000
278
FERGUSON, TIM DR.
$1,000
279
FICHT, THOMAS A. MR.
$1,000
280
FINCH, RANDY
$1,000
281
FLANARY, BILLIE J.
$1,000
282
FOLLEY, GREGORY
$1,000
283
FOWLER, CHARLES
$1,000
284
FOWLER, R.
$1,000
285
FREEDLUND, JOY A.
$1,000
286
GAFFEY, MARY H.
$1,000
287
GEDDES, DOUGLAS G.
$1,000
288
GINSBURG, SHARON LEE
$1,000
289
GOLDMAN, ROBERT
$1,000
290
GOLDSBURY, CHRISTOPHER MR. JR.
$1,000
291
GRIFFIN, BILL
$1,000
292
GROSSMAN, JENNIFER MRS.
$1,000
293
HALEY, DAVID MR.
$1,000
294
HALL, CHARLES
$1,000
295
HARTMAN, MARLIN N.
$1,000
296
HATHORN, SAMUEL MR.
$1,000
297
HAYNES, NELL E. MS.
$1,000
298
HEADLEY, HARRY P.
$1,000
299
HEIN, ALBERT C. LT. COL.
$1,000
300
HENRY, WEILAND ALEXANDER III
$1,000
301
HERRICK, CATHY
$1,000
302
HESLEP, DONALD B. MR.
$1,000
303
HILLIARD, TOWNSEND
$1,000
304
HORNSBY, RICHARD
$1,000
305
HOUSE, LOUIS T.
$1,000
306
HOWARD, GLENN
$1,000
307
HUBBARD, JOHN DOUGLAS MR.
$1,000
308
HUNTINGTON, LOUIS H. MR.
$1,000
309
HYNES, TERENCE
$1,000
310
IRBY, WILLIAM TY
$1,000
311
IVY, CONWAY G. MR.
$1,000
312
JOHNSON, PHILIP MR.
$1,000
313
JOHNSON, ROB A. MR.
$1,000
314
JOHNSON, SUSAN MS.
$1,000
315
JONES, BRIAN
$1,000
316
JONES, ROLAND MR. JR.
$1,000
317
JORDAN, RICHARD E. MR. II
$1,000
318
KADERABEK, FRANK
$1,000
319
KIRCHNER, RICHARD MR.
$1,000
320
KOETHER, BERNARD G. MR.
$1,000
321
KUNST, GREG
$1,000
322
LARSON, GEORGE R. MR.
$1,000
323
LEE, SUSAN
$1,000
324
LEMMONS, JOHN
$1,000
325
LENNON, JEANNE M.
$1,000
326
LERCHBACKER, ALAN
$1,000
327
LESTER, CATHY
$1,000
328
LEWIS, JEFFREY B. MR.
$1,000
329
LINAM, BOB MR.
$1,000
330
LOVE, MARY
$1,000
331
LYNCH, RICHARD
$1,000
332
MALKO, PIERRE
$1,000
333
MARTINO, GISELLE
$1,000
334
MCFADDEN, CAROL
$1,000
335
MILLER, REGINALD
$1,000
336
MILLIGAN, DANE MR.
$1,000
337
MILLSAP, WILLIAM J.
$1,000
338
MINIAT, NANCY
$1,000
339
MORRIS, JOE
$1,000
340
MORRISON, M. EDWARD DR.
$1,000
341
NEWBERRY, KARMA
$1,000
342
NOCELLA, BERNARD
$1,000
343
O'BRIEN, PATRICIA MRS.
$1,000
344
OLIPHANT, DON
$1,000
345
OLSEN, JEFF
$1,000
346
OVERTON, JANET T.
$1,000
347
PANKEY, PETER S. MR.
$1,000
348
PARKER, ROBERT E. MR.
$1,000
349
PERRY, MARK
$1,000
350
PFISTER, DICK
$1,000
351
PIERCE, FREDERICK W.
$1,000
352
PORTER, THOMAS H. MR. JR.
$1,000
353
POTTER, GARY
$1,000
354
POTTER, MARIE MRS.
$1,000
355
POWERS, MATTHEW R.
$1,000
356
PUSTA, LENORA H. MS.
$1,000
357
QUINN, JOHN THOMAS
$1,000
358
RAHAL, ROBERT
$1,000
359
RAIRIGH, JAMES MR.
$1,000
360
RIVARD, MATTHEW
$1,000
361
ROTHMAN, JOEL MR.
$1,000
362
SANDERS, JEFFERY
$1,000
363
SAWYER, STEVEN
$1,000
364
SCHLOSSER, DENNIS MR.
$1,000
365
SCHULTZ, DENNIS MR.
$1,000
366
SENNETT, DAVID MR.
$1,000
367
SHAMOUN, RONSON
$1,000
368
SHAW, MARGOT
$1,000
369
SHELLENBERGER, SYLVIA
$1,000
370
SHIVELY, STEPHEN MR.
$1,000
371
SHULMAN, LLOYD J. MR
$1,000
372
SHUMWAY, CHAD MR.
$1,000
373
SIGLER, ROBERT W. MR.
$1,000
374
SLEEM, RAMI
$1,000
375
SLOAN, SHIRLEY
$1,000
376
SMITH, ANDREW L.
$1,000
377
SMITH, DANIEL CHYLE
$1,000
378
SMITH, FREDERICK
$1,000
379
SPURLOCK, TOM
$1,000
380
SREDNICKI, GINNY
$1,000
381
SREDNICKI, VIRGINIA E.
$1,000
382
STAFFORD, JOHN J.
$1,000
383
STAI, DIAN GRAVES MS
$1,000
384
STEPHENS, WILLIAM D.
$1,000
385
STEWART, CHERYL
$1,000
386
STRAKA, MICHELE
$1,000
387
SWEENEY, DENISE
$1,000
388
SWEENEY, MICHAEL CHRIS
$1,000
389
SYRE, STEPHEN E. MR.
$1,000
390
SYVERSEN, TERESA
$1,000
391
TAIT, PATSY
$1,000
392
TAYLOR, DANIEL J.
$1,000
393
TAYLOR, GLENNA S.
$1,000
394
THEMEA, SEAN
$1,000
395
THOMSON, HARRY
$1,000
396
UTHOFF, JARROD
$1,000
397
VECELLIO, LEO A. MR. JR.
$1,000
398
WADE, ROGER MR.
$1,000
399
WAITE, NORMAN MR.
$1,000
400
WALSH, LARRY R. MR.
$1,000
401
WILLIAMS, TODD
$1,000
402
WILLIE, STEVE M. MR.
$1,000
403
WOLTMAN, DICK
$1,000
404
YEULIN, STEPHEN
$1,000
405
ZESSIN, ROGER ALAN MR.
$1,000
406
ZINTEL, LANNY MR
$1,000
407
ZVTECK, ROBERT WALLACE
$1,000
408
ZYNDA, STEPHEN
$1,000
409
LIPTAK, DAVID MR.
$1,000
410
MAXWELL, THOMAS MR.
$1,000
411
NORVELL, DANIEL ROGER MR.
$900
412
SPEARS, ASHLEY
$900
413
BON, MIKEL
$850
414
SHAFFER, SUZANNE
$842
415
COMINSKI, VIOLET MS.
$800
416
MELTON, JOHNNIE G. MRS.
$800
417
POHL, BETTY J. MS.
$800
418
QUINTERO, ALVARO FLORES MR.
$800
419
FARRELL, THOMAS MR.
$785
420
BERNSTEIN, RICHARD A. MR.
$750
421
FEEHERY, JOHN
$750
422
MATSUOKA, CHIYOKO
$750
423
MELVILLE, DAVID B. MR. WWII VET.
$750
424
HEIST, MARY L. MRS.
$700
425
ROMANS, JERRY MR.
$700
426
MARCINEK, LANA
$601
427
CIMINO, SHIRLEY R.
$600
428
CLORE, OREN B.
$600
429
DEMASI, LINDA K. MS.
$600
430
EVANS, JOHN PALMER MR.
$600
431
FRANCIS, KAY E. MISS
$600
432
GUBICH, RICK F.
$600
433
HANCOCK, JANE MS.
$600
434
HORTIN, BRUCE T. MR.
$600
435
SHIRK, ARTHUR
$600
436
SNODGRASS, JAMES MR.
$600
437
SWAIN, LEONARD
$600
438
SCHUETTE, EVELYN M. MS.
$565
439
KINNEY, RONALD F. MR.
$564
440
FINNEY, JAMES A. JR.
$510
441
GONZALEZ, FERNANDO
$510
442
CASTEEL, MARTHA R. MS.
$501
443
NELSON, RICHARD P. MR.
$501
444
OHMS, DONALD MR.
$501
445
OLIVER, WYNELL C. MS.
$501
446
ACH, CHRISTIAN H. MR.
$500
447
AGRUSA, RUSSELL L.
$500
448
ANDERSON, STEVEN O. DR.
$500
449
ANDRE, BEN MR.
$500
450
ANGLE, DORIS JEAN
$500
451
ASENSIO, CHARLES
$500
452
AYRES, DONALD B. MR.
$500
453
BABBAGE, BRIAN
$500
454
BABBAGE, ROBERT A. MR. JR.
$500
455
BABCOCK, KAREN D. MS.
$500
456
BAILEY, BRUCE MR.
$500
457
BAKER, STEVE
$500
458
BALE, TOMMY
$500
459
BARBI, LESLIE MS.
$500
460
BATTMER, ROBERT E. MR. M.D.
$500
461
BAUCUM, TREY
$500
462
BENEDETT, DAVID C. MR.
$500
463
BERNARDO, ASHLEY
$500
464
BIRD, KENNETH
$500
465
BISHOP, SUSAN S. MRS.
$500
466
BLACK, GERALD R. MRS.
$500
467
BOEMAN, CARL G.
$500
468
BOGENSCHUTZ, ROBERT
$500
469
BONAR, IVA KATHLEEN MS
$500
470
BONNELL, REBECCA JUANITA MRS.
$500
471
BOSWELL, BRAD
$500
472
BOUFFARD, JOSE
$500
473
BOYD, BRUCE
$500
474
BRAGG, CAROLYN ANN MS. RET.
$500
475
BREWER, MARILYN G.
$500
476
BROOKS, HERBERT J. MR.
$500
477
BROOKS, JERALD MR.
$500
478
BROWN, ALLAN F. MR.
$500
479
BROWN, FRED
$500
480
BROWN, JOANN C. MS.
$500
481
BUISSON, MARGARET A. MS.
$500
482
BURNS, RICHARD C. MR. JR.
$500
483
CALDWELL, EUGENE
$500
484
CAMPBELL, WILLIAM R. LTC. RET.
$500
485
CARLSON, GISELA
$500
486
CARLSON, VICTOR JOHN
$500
487
CARPENTER, DIANA
$500
488
CARSON, GLENN MR.
$500
489
CARTRIGHT, GARY
$500
490
CASALE, MARK J. MR.
$500
491
CATHCART, CLIFTON H.
$500
492
CAUDILL, SANFORD DAN MR.
$500
493
CAWTHON, CHERYL MS.
$500
494
CETLIN, DENNIS MR.
$500
495
CHADDOCK, CRAIG M. MR. SR.
$500
496
CHAPMAN, ELLEN A.
$500
497
CHEN, JONG
$500
498
CHEN, SEN-HENG
$500
499
CHESTER, DALTON
$500
500
CHESTER, DAVID
$500
501
CHOATE, ARTHUR B. MR.
$500
502
CHRISTENSEN, CHRISTIAN M. MR.
$500
503
CLARK, JERRY D. DR.
$500
504
CLEGG, MARSHALL T. MR.
$500
505
COATES, PAM MS.
$500
506
COLLINS, JOHN W. MR. III
$500
507
COLLINS, KATHERINE C. MS.
$500
508
COMBS, HARRY
$500
509
CONGER, ROBERT C.
$500
510
COOPER, TERRY A. MR.
$500
511
COURTNEY, BETTY
$500
512
CRAIN, STEVE
$500
513
CREAMER, EMMA SUE MS.
$500
514
CREGO, LAI MING
$500
515
CREWS, LANA
$500
516
CROWLEY, ARVIL
$500
517
CRUM, JERALD M. MR.
$500
518
CRUSON, MICHAEL G. MR.
$500
519
CUBITT, JAMES CHARLES MR.
$500
520
CULBERTSON, JOHN MR.
$500
521
CUMMINGS, BILL
$500
522
CURNIN, BRENDA MS.
$500
523
CZYZYK, FARIMA A.
$500
524
CZYZYK, JOSEPH A. MR.
$500
525
DALTON, JAMES C.
$500
526
DAMON, CAROLYN J. MRS.
$500
527
DANE, JOHN MR.
$500
528
DAVIS, SUSAN J. MS.
$500
529
DAVIS, THEODORA
$500
530
DEITRICK, KARIN
$500
531
DEPIETRO, ROBERT MR.
$500
532
DEREZINSKI, KATHRYN
$500
533
DESROCHERS, SHIRLEY P. MS.
$500
534
DOAN, MONICA G. MS.
$500
535
DOBSKI, ANTHONY E.
$500
536
DODDS, HELEN Z. MS.
$500
537
DODDS, JAMES W. MR
$500
538
DORSEY, ROBERT
$500
539
DOTSON, EMILY MRS
$500
540
DOWLING, SHIRLEY T.
$500
541
DOWNING, JOHN E.
$500
542
DROCHELMAN, WILLIAM
$500
543
DUDLEY, SYDNEY
$500
544
DUNCAN, ROBERT M. MR.
$500
545
EDOSOMWAN, JOHNSON
$500
546
EGGERS, ERNEST A. MR.
$500
547
ELLYSON, ALVANIA TAYLOR MR.
$500
548
EMBRY, RUTH
$500
549
ENDICO, MICHAEL C.
$500
550
ESCHNER, ERNA E. MRS.
$500
551
ESTES, CONSTANCE MS.
$500
552
EZELL, PATRICIA N.
$500
553
FERRARINI, DAVID
$500
554
FIDLER, MICHAEL MR.
$500
555
FLACHSMANN, PETER
$500
556
FLETCHER, MARGUERITE A. MS.
$500
557
FLYNN, JOHN J. MR JR
$500
558
FORCHT, TERRY E. MR.
$500
559
FOX, ALAN
$500
560
FRANKLIN, MARC MR.
$500
561
FRENCH, JOSEPH
$500
562
FRENCH, SUSAN
$500
563
FRIES, LOUIS F. MR. III
$500
564
FROST, MICHAEL
$500
565
FUCHS, FRANK
$500
566
FULLER, GILLIAN
$500
567
GALLA, JOHN
$500
568
GALLATIN, ANDREW MR.
$500
569
GALLIHER, DAVID MR.
$500
570
GAMUEDA, JESSE
$500
571
GEARHISER, BEVERLY MS.
$500
572
GEORGE, LAWRENCE
$500
573
GERARD, MARION A. MRS.
$500
574
GOLDBERG, MARVIN A.
$500
575
GOLDRING, WILLIAM
$500
576
GOSSETT, TED
$500
577
GOSSMAN, JOAN M. MS.
$500
578
GRADINGER, CHRISTINA MS.
$500
579
GREGORY, JOSEPH
$500
580
GRIGGS, ROGER MR.
$500
581
GRIOT, RICHARD MR.
$500
582
GROW, DAVID MR.
$500
583
HAGEN, DEBORAH
$500
584
HALABY, MARY
$500
585
HAMEL, JOHN E. MR
$500
586
HAN, AMY
$500
587
HARMS, DUANE
$500
588
HARRISON, PHYLLIS
$500
589
HAVENS, JOEY
$500
590
HAWTHORNE, LYNN M. MRS.
$500
591
HEAPHY, MICHAEL R. MR.
$500
592
HEBOLD, WALTER C. MR.
$500
593
HEIDECKE, ALBERT J. MR.
$500
594
HELMERICH, PEGGY MRS.
$500
595
HENDERSON, ROBERT WEBB MR
$500
596
HENTHORNE, KATHERINE H. MS.
$500
597
HERNANDEZ, ELIEZER
$500
598
HESS, MARGARET ANN MS
$500
599
HETTINGER, RICK
$500
600
HILL, MARTIN
$500
601
HILLERBY, KAY
$500
602
HOBBS, CRAIG S.
$500
603
HODGDON, JANIE MS.
$500
604
HOLLINS, LEONA JEAN MRS.
$500
605
HOLLOWAY, THOMAS H. MR. JR.
$500
606
HOOK, JOANNE H. MRS.
$500
607
HORST, VERONYCA CASTANON
$500
608
HORSTICK, DAVID P.
$500
609
HOWARD, WILLIAM K. MR.
$500
610
HYATT, DONALD MR.
$500
611
HYATT, NORMA MRS.
$500
612
HYSLOP, CLAYTON J.
$500
613
INGERSON, WANDA MS.
$500
614
JABLONSKI, JOYCE M. MS
$500
615
JACKSON, GORDON E. MR.
$500
616
JACKSON, TED MR.
$500
617
JACKSON, WESLEY G.
$500
618
JOHNSON, BO MR.
$500
619
JOHNSON, DOUGLAS MR.
$500
620
JOHNSTON, MERILYN B. MR.
$500
621
JONES, TROY R. DR.
$500
622
JORGENSEN, FREDA MS.
$500
623
JUDGE, LUCAS
$500
624
KAMPE, DIANE
$500
625
KELLEN, MARK DR.
$500
626
KELLER, ARLEENE
$500
627
KENDALL, LINDA G. MS.
$500
628
KHAN, BASHIR
$500
629
KIMBLE, ERIC
$500
630
KIRK, ADRIAN F. MR. JR.
$500
631
KISTER, RONALD MR.
$500
632
KLEINBUB, FREDRICK MR.
$500
633
KMIECIK, JOSEPH E. MR.
$500
634
KNIGHT, LORA
$500
635
KNOCK, RICHARD MR.
$500
636
KOENIG, DEAN B. MR.
$500
637
KRUEGER, P.J.
$500
638
LACEY, JEANETTE J. MS.
$500
639
LANGHOLF, EUGENE F. MR.
$500
640
LAROCCA, RENATO V. DR. MD.
$500
641
LASSLETT, DONNA R. MS.
$500
642
LEBARRE, LARRY
$500
643
LEWIS, BILL MR.
$500
644
LEWIS, CHARLES MR. III
$500
645
LUKE, DEBRA
$500
646
LYNN, THEODORA
$500
647
MACDONALD, CATHARINE
$500
648
MACDONALD, PAUL ANDREW
$500
649
MACDONALD, SUSAN G. MRS
$500
650
MAGUIRE, STEPHEN
$500
651
MAH, FRANCIS
$500
652
MANGIONE, MIKE MR.
$500
653
MANN, DONNA MS.
$500
654
MAPLE, RALPH MR.
$500
655
MARINO, CHRIS
$500
656
MARQUIS, VALERIE
$500
657
MCALPINE, KEITH
$500
658
MCCAW, JOHN MR.
$500
659
MCDONALD, JUDY MS.
$500
660
MCDONALD, THOMAS
$500
661
MCGUIRE, SHARON R. MS.
$500
662
MCQUEEN, WILMA L. MRS.
$500
663
MEIER, CRAIG A. MR.
$500
664
MERINOFF, ALICIA
$500
665
MERRY, PETER MR.
$500
666
METCALFE, NORMAN
$500
667
MIDDLETON, DALE B. MR.
$500
668
MILLER, DAVID MR.
$500
669
MILLER, HARVEY
$500
670
MILLER, STEPHEN
$500
671
MIRSKY, CYNTHIA
$500
672
MOEHREN, HEINER H. MR.
$500
673
MOEHRING, ROBERT
$500
674
MOELLER, THOMAS
$500
675
MOHOLLAND, BARBARA
$500
676
MORRIS, ROBERT E. MR. JR.
$500
677
MOYER, JON M. MR.
$500
678
MULZER, ANDREA
$500
679
MUMFORD, JUDITH L.
$500
680
MURATA, HENRY Y. MR.
$500
681
MYERS, BOYD DOUGLAS
$500
682
NIKKEL, JOHN G. MR.
$500
683
O'CONNOR, WILLIAM C. MR.
$500
684
O'HARE, JOHN MR.
$500
685
ODOM, MARCIA COLEMAN MS
$500
686
OKUMOTO-MILLER, KATHRYN K. MS.
$500
687
ORR, KEITH
$500
688
OWENS, CARL
$500
689
PADDECK, EDWARD L. MR.
$500
690
PARKER, PATRICIA
$500
691
PARKER, SUSAN MS.
$500
692
PAULSON, ROBERT
$500
693
PENNINGTON, SHERRIE L. MS.
$500
694
PETERSON, SHARON
$500
695
PFANNENSTIEL, JOHN
$500
696
PHILIPPO, ANN MS.
$500
697
PHILLIPS, ROBERT A. MR.
$500
698
PILLOW, JANELLE MS.
$500
699
PINK, JEFF
$500
700
PLACEK, RICHARD MR.
$500
701
PLATT, ELAINE T.
$500
702
POOR, WESLEY SHAUN
$500
703
POORTINGA, JACK MR.
$500
704
POPLIN, KAY MS.
$500
705
PORTER, BART D.
$500
706
POWELL, FITZHUGH K. MR.
$500
707
POWELL, L. FAYE MS.
$500
708
PRATER, TILMAN J. MR. III
$500
709
PRZILAS, PHYLLIS MRS.
$500
710
PUCKETT, RANDELL VIOYT MR.
$500
711
PULLIAM, MARK E.
$500
712
PURVIS, RONALD
$500
713
RAFF, PATRICIA MS.
$500
714
RAFFIN, BERNADETTE MRS
$500
715
REILLY, JOHN F.
$500
716
REINHARD, DONALD G. MR.
$500
717
RESCH, JAMES
$500
718
RESLER, CARL
$500
719
REYNOLDS, MARY SHARON MRS.
$500
720
RHEIN, PETER MR
$500
721
RIGGS, RUSSELL P. MR.
$500
722
RISIUS, BARBARA F. DR. M.D.
$500
723
ROBERTS, BEN
$500
724
ROBINETTE, VICTORIA A.
$500
725
ROE, RICHARD
$500
726
ROGERS, CLARENCE B.
$500
727
RUDOLPH, RUTH S. MS
$500
728
RUSSELL, ANDREW
$500
729
RUTLEDGE, WILLIAM H. MR. JR.
$500
730
RYBOLT, WILLIAM
$500
731
SAMPLE, WILLIAM S. MR. WWII VET
$500
732
SANBRANO, PAUL MR.
$500
733
SAWYER, JOHN E. MSGT RETIRED
$500
734
SAXER, NORMAN K.
$500
735
SCHAEFER, ROBERT W. MR.
$500
736
SCHELLER, JOSEPH B. MR
$500
737
SCHMIDT, CHARLES MR.
$500
738
SCHOLL, CHESTER L. MR.
$500
739
SCHUBERT, MARGARET MRS.
$500
740
SCHULMAN, JOSEPH
$500
741
SCHULTZ, ROBERT
$500
742
SCHWARZ, ERIC R.
$500
743
SCHWEEN, JOHN R. MR. JR.
$500
744
SEAMON, EDWARD B.
$500
745
SEARS, LARRY DR.
$500
746
SECOR, RICHARD MR.
$500
747
SEKOWSKI, KATHERINE J. MRS.
$500
748
SENSING, LUCY T. MRS.
$500
749
SHAW, JOHN MR.
$500
750
SHAW, WILLIAM W. MR.
$500
751
SHINKLE, R KEITH MR.
$500
752
SHLANSKY, DAVID
$500
753
SHUPE, JEFFERY
$500
754
SIMON, BEVERLY A. MS.
$500
755
SIMONS, CARL I. MR.
$500
756
SINGLETON, ROBERT F.
$500
757
SITKO, JAN B.
$500
758
SLAVIK, PAUL MR.
$500
759
SMITH, ELENOR C. MRS.
$500
760
SMITH, FRAN
$500
761
SMITH, GENE E.
$500
762
SNOWBARGER, RONALD MR.
$500
763
SPARKS, SHAWN
$500
764
SPOLAR, DICKSIE
$500
765
SREDNICKI, RICHARD J. MRS.
$500
766
STAHL, TOM MR.
$500
767
STAINBROOK, FRED LEROY
$500
768
STARKEY, ROD MR.
$500
769
STERN, JAMES MR.
$500
770
STEVENS, THOMAS
$500
771
STRAUCH, RANDOLPH
$500
772
STROMQUIST, DAVID
$500
773
STUCKERT, JAMES MR.
$500
774
SUMMERVILL, CHRISTIE
$500
775
SUTER, GEORGE B. MR.
$500
776
SYVRUD, JAMES P. MR.
$500
777
TAFOYA, SAUNDRA J.
$500
778
TALLARD, JEFFREY E.
$500
779
TALLMAN, ROBERT E. MR. JR.
$500
780
TESCHAN, PAUL DR.
$500
781
THEBERGE, BARBARA
$500
782
THOMPSON, DAVID
$500
783
TODD, GEORGE W. MR.
$500
784
TRIBLE, JOHN R. MR. II
$500
785
TROMETTER, VINCENT P.
$500
786
TUROWSKI, DANIEL M. MR.
$500
787
VAN KUIKEN, NORMA MRS
$500
788
VANDERWEY, GINA MS.
$500
789
VANNELL, HARRY III
$500
790
VANWYK, CHRIS MRS.
$500
791
VERKLER, DIANNE J. MS.
$500
792
VIZCAINO, ANTONIO MR.
$500
793
VON DER HOFEN, HAN
$500
794
VUCINICH, TINA MS.
$500
795
WAHL, TAMI L.
$500
796
WAINRIGHT, JOSEPH MR.
$500
797
WALKER, JACK MR.
$500
798
WALL, ARVEL
$500
799
WARD, LINDA
$500
800
WASHAM, REBECCA
$500
801
WEBB, ELIZABETH
$500
802
WEBER, BRAD WESLEY MR.
$500
803
WECK, THOMAS
$500
804
WEGNER, RUTH ANN MS.
$500
805
WELCH, CLARE A. MS.
$500
806
WELDON, DIANE
$500
807
WESTCAMP, JESSIE G. MRS.
$500
808
WHIPPLE, MICHAEL MR.
$500
809
WIEGAND, RODNEY W. MR.
$500
810
WIESEMANN, RICHARD J. MR.
$500
811
WIKSTROM, LESLIE
$500
812
WILLIAMS, ANGELA H. MS.
$500
813
WILLIAMSON, BARRY D. MR.
$500
814
WINFREE, JAMES HAMILTON
$500
815
WOGAHN, BRENT M. MR.
$500
816
WOLFSHOHL, WILLIAM
$500
817
WRIGHT, MARY
$500
818
ZIMMERMAN, BILLIE MS.
$500
Cosponsors & Their Campaign Finance
This bill has 1 cosponsors. Below are their top campaign contributors.
Sen. Peters, Gary C. [D-MI]
ID: P000595
Top Contributors
10
1
MATCH-E-BE-NASH-SHE-WISH BAND OF POTTAWATOMI INDIANS
OrganizationSHELBYVILLE, MI
$3,300
Oct 22, 2024
2
STRATEGIC LINK CONSULTING, LP
OrganizationKENNESAW, GA
$3,300
May 28, 2024
3
MUCKLESHOOT INDIAN TRIBE
OrganizationAUBURN, WA
$3,300
Aug 11, 2023
4
OTOE MISSOURIA TRIBE OF OKLAHOMA
OrganizationRED ROCK, OK
$2,900
May 29, 2024
5
HABEMATOLEL POMO OF UPPER LAKE TRIBE OF CALIFORNIA
OrganizationUPPER LAKE, CA
$2,900
May 29, 2024
6
TURTLE MOUNTAIN BAND OF CHIPPEWA TRIBE OF NORTH DAKOTA
OrganizationBELCOURT, ND
$2,900
May 28, 2024
7
CHEROKEE NATION
OrganizationTAHLEQUAH, OK
$2,500
Jan 9, 2024
8
HABEMATOLEL POMO OF UPPER LAKE TRIBE OF CALIFORNIA
OrganizationUPPER LAKE, CA
$2,500
Jun 30, 2024
9
OTOE MISSOURIA TRIBE OF OKLAHOMA
OrganizationRED ROCK, OK
$2,500
Jun 30, 2024
10
TURTLE MOUNTAIN BAND OF CHIPPEWA TRIBE OF NORTH DAKOTA
OrganizationBELCOURT, ND
$2,500
Jun 30, 2024
Donor Network - Sen. Paul, Rand [R-KY]
PACs
Organizations
Individuals
Politicians
Hub layout: Politicians in center, donors arranged by type in rings around them.
Loading...
Showing 51 nodes and 23 connections (47 secondary connections hidden)
Total contributions: $97,400
Top Donors - Sen. Paul, Rand [R-KY]
Showing top 19 donors by contribution amount
19 Individuals
Industry Impact
Which industries are materially affected by specific provisions in this bill. 5 harmed.
- −Biotech & Researchconfidence 0.90
The bill establishes a Life Sciences Research Security Board that reviews and can block Federal funding for high-risk life sciences research, including gain of function research and dual use research of concern involving high-consequence pathogens. This imposes regulatory oversight and potential delays or denials of funding for biotech firms engaged in such research, constituting a clear cost (new regulation, enforcement, market contraction). Sections 7904, 7905, and 7906 detail the Board's auth
- −Pharmaceuticalsconfidence 0.85
The bill's review process applies to life sciences research, which includes pharmaceutical and biomedical research (as defined in section 7901(10)(B)). Pharmaceutical companies receiving Federal funding for research involving high-consequence pathogens or gain of function research would be subject to Board approval, potentially delaying or blocking awards. This constitutes a clear cost via new regulatory oversight and enforcement mechanisms under sections 7905 and 7906.
- −Health Insuranceconfidence 0.80
The bill creates a Life Sciences Research Security Board that reviews and can block Federal funding for high-risk life sciences research, which includes pharmaceutical and biomedical research. This could reduce funding for health insurance-related research (e.g., drug development, vaccine research) that insurers may rely on for coverage decisions, potentially harming the health insurance industry by limiting innovation in treatments they cover. Section 7906(a)(1)(B) gives the Board authority to
- −Hospitals & Health Systemsconfidence 0.75
Hospitals and health systems that conduct life sciences research (e.g., clinical trials, biomedical studies) with Federal funding may be subject to the Board's review if their research involves high-risk life sciences as defined. This could delay or restrict funding for such research, imposing a cost via new regulatory requirements. Section 7901(10) includes biomedical research, and sections 7905-7906 apply to agencies awarding such funding, which includes NIH-funded hospital research.
- −Medical Devicesconfidence 0.70
Medical device companies engaged in life sciences research (e.g., biomaterials, implantable devices, diagnostics) that receive Federal funding for research involving high-consequence pathogens or gain of function research would fall under the Board's purview. This could impose delays or denials of funding, representing a clear cost via new regulatory oversight. Section 7901(10) includes biomedical research and techniques, which encompasses medical device R&D.
Who funds the sponsor on these industries
For each industry this bill affects, here's what the sponsor (Sen. Paul, Rand [R-KY])received from donors associated with that industry during the 2022–present cycles. Donations are not proof of intent — they are a record of who funds the people writing the law.
Industries this bill HARMS
- Health Insurance$530from 22 contributions
- GUTIERREZ, JOANNA$450
- MOELLER, LYNN$80
- Pharmaceuticals$401from 2 contributions
- MYLAN, VICKI MS.$401
- from 8 contributions
- DELLARMO, DIANE$200
- BELLONI, PAULA$120
- Medical Devices$150from 1 contribution
- STRYKER, NORMAN$150
Project 2025 Policy Matches
This bill shows semantic similarity to the following sections of the Project 2025 policy document.AI-enhanced analysis provides detailed alignment ratings.
Environmental Protection Agency
Moderate
Vector: 65%Pages: 470-472AI Enhanced
AI Analysis:
"Both the bill and the Project 2025 EPA section emphasize strengthening oversight and accountability of scientific activities through independent review mechanisms and ensuring congressional authorization, though they apply to different domains (life sciences research vs. EPA science programs)."
Key themes:oversightindependent reviewscientific accountabilitycongressional authorizationrisk assessment
— 437 — Environmental Protection Agency l Suspend and review the activities of EPA advisory bodies, many of which have not been authorized by Congress or lack independence, balance, and geographic and viewpoint diversity. l Retract delegations for key science and risk-assessment decisions from Assistant Administrators, regional offices, and career officials. l Eliminate the use of Title 42 hiring authority that allows ORD to spend millions in taxpayer dollars for salaries of certain employees above the civil service scale. l Announce plans to streamline and reform EPA’s poorly coordinated and managed laboratory structure. Budget: Back-to-Basics Rejection of Unauthorized or Expired Science Activities A top priority should be the immediate and consistent rejection of all EPA ORD and science activities that have not been authorized by Congress. In FY 2022, according to EPA’s opaque budgeting efforts, science and technology activ- ities totaled nearly $730 million. EPA’s FY 2023 budget request for the Office of Research and Development seeks funds for more than 1,850 employees—a dramatic increase for what is already the largest EPA office with well above 10 percent of the agency’s workforce.44 ORD conducts a wide-ranging series of science and peer review activities, some in support of regulatory programs established by our envi- ronmental laws, but often lacks authority for these specific endeavors. Several ORD offices and programs, many of which constitute unaccountable efforts to use scientific determinations to drive regulatory, enforcement, and legal decisions, should be eliminated. The Integrated Risk Information System, for example, was ostensibly designed by EPA to evaluate hazard and dose-response for certain chemicals. Despite operating since the 1980s, the program has never been authorized by Congress and often sets “safe levels” based on questionable science and below background levels, resulting in billions in economic costs. The program has been criticized by a wide variety of stakeholders: states; Congress; the National Academies of Science, Engineering, and Medicine (NASEM); and the U.S. Govern- ment Accountability Office (GAO), among others. EPA has failed to implement meaningful reforms, and this unaccountable program threatens key regulatory processes as well as the integrity of Clean Air Act and TSCA implementation. Needed EPA Advisory Body Reforms EPA currently operates 21 federal advisory committees.45 These committees often play an outsized role in determining agency scientific and regulatory policy, — 438 — Mandate for Leadership: The Conservative Promise and their membership has too often been handpicked to achieve certain politi- cal positions. In the Biden Administration, key EPA advisory committees were purged of balanced perspectives, geographic diversity, important regulatory and private-sector experience, and state, local, and tribal expertise. Contrary to con- gressional directives and recommendations from the GAO and intergovernmental associations, these moves eviscerated historic levels of participation on key com- mittees by state, local, and tribal members from 2017 to 2020. As a result, a variety of EPA regulations lack relevant scientific perspectives, increasing the risks of economic fallout and a failure of cooperative federalism. EPA also has repeatedly disregarded legal requirements regarding the role of these advisory committees and the scope of scientific advice on key regulations.46 Needed Science Policy Reforms Instead of allowing these efforts to be misused for scaremongering risk com- munications and enforcement activities, EPA should embrace so-called citizen science and deputize the public to subject the agency’s science to greater scrutiny, especially in areas of data analysis, identification of scientific flaws, and research misconduct. In addition, EPA should: l Shift responsibility for evaluating misconduct away from its Office of Scientific Integrity, which has been overseen by environmental activists, and toward an independent body. l Work (including with Congress) to provide incentives similar to those under the False Claims Act47 for the public to identify scientific flaws and research misconduct, thereby saving taxpayers from having to bear the costs involved in expending unnecessary resources. l Avoid proprietary, black box models for key regulations. Nearly all major EPA regulations are based on nontransparent models for which the public lacks access or for which significant costs prevent the public from understanding agency analysis. l Reject precautionary default models and uncertainty factors. In the face of uncertainty around associations between certain pollutants and health or welfare endpoints, EPA’s heavy reliance on default assumptions like its low-dose, linear non-threshold model bake orders of magnitude of risk into key regulatory inputs and drive flawed and opaque decisions. Given the disproportionate economic impacts of top-down solutions, EPA should implement an approach that defaults to less restrictive regulatory outcomes.
Environmental Protection Agency
Weak
Vector: 65%Pages: 470-472AI Enhanced
AI Analysis:
"The bill focuses on creating a board to oversee high-risk life sciences research for national security, while the Project 2025 EPA section concerns reforming EPA advisory bodies, hiring practices, lab structure, and rejecting unauthorized EPA science activities. Both share a theme of increased oversight of federal scientific endeavors, but their substantive domains and objectives differ significantly."
Key themes:scientific oversightaccountabilityfederal science activitiesreview processes
— 437 — Environmental Protection Agency l Suspend and review the activities of EPA advisory bodies, many of which have not been authorized by Congress or lack independence, balance, and geographic and viewpoint diversity. l Retract delegations for key science and risk-assessment decisions from Assistant Administrators, regional offices, and career officials. l Eliminate the use of Title 42 hiring authority that allows ORD to spend millions in taxpayer dollars for salaries of certain employees above the civil service scale. l Announce plans to streamline and reform EPA’s poorly coordinated and managed laboratory structure. Budget: Back-to-Basics Rejection of Unauthorized or Expired Science Activities A top priority should be the immediate and consistent rejection of all EPA ORD and science activities that have not been authorized by Congress. In FY 2022, according to EPA’s opaque budgeting efforts, science and technology activ- ities totaled nearly $730 million. EPA’s FY 2023 budget request for the Office of Research and Development seeks funds for more than 1,850 employees—a dramatic increase for what is already the largest EPA office with well above 10 percent of the agency’s workforce.44 ORD conducts a wide-ranging series of science and peer review activities, some in support of regulatory programs established by our envi- ronmental laws, but often lacks authority for these specific endeavors. Several ORD offices and programs, many of which constitute unaccountable efforts to use scientific determinations to drive regulatory, enforcement, and legal decisions, should be eliminated. The Integrated Risk Information System, for example, was ostensibly designed by EPA to evaluate hazard and dose-response for certain chemicals. Despite operating since the 1980s, the program has never been authorized by Congress and often sets “safe levels” based on questionable science and below background levels, resulting in billions in economic costs. The program has been criticized by a wide variety of stakeholders: states; Congress; the National Academies of Science, Engineering, and Medicine (NASEM); and the U.S. Govern- ment Accountability Office (GAO), among others. EPA has failed to implement meaningful reforms, and this unaccountable program threatens key regulatory processes as well as the integrity of Clean Air Act and TSCA implementation. Needed EPA Advisory Body Reforms EPA currently operates 21 federal advisory committees.45 These committees often play an outsized role in determining agency scientific and regulatory policy,
Department of Energy and Related Commissions
Weak
Vector: 63%Pages: 425-427AI Enhanced
AI Analysis:
"The bill focuses on biosecurity oversight of life sciences research, while the Project 2025 policy emphasizes U.S. scientific dominance, technology transfer, and national security in energy-related R&D (AI, cybersecurity, space, natural resources). There is minimal thematic overlap, as the bill does not address DOE, Office of Science, or technology commercialization priorities outlined in the policy."
Key themes:national securityresearch oversighttechnology protection
— 393 — Department of Energy and Related Commissions l Ensure that R&D funds are used for projects that protect and advance that edge. l Ensure that successful advances, with a focus on new natural resource development technologies, artificial intelligence, cybersecurity, and space, are transferred swiftly to American interests in the private sector. New Policies l Focus on benefits to Americans. OTT’s operations should be based on the recognition that the new technologies generated by American taxpayers’ investment in DOE are a significant national security asset rather than some neutral scientific gift to humanity. l Increase oversight and coordination. OTT needs to be vigilant in overseeing and coordinating OTT offices associated with each National Lab. For security and economic espionage reasons, the work funded by the American people needs to be protected, and when commercialized, it needs to go to American businesses. OFFICE OF SCIENCE (SC) Mission/Overview The Office of Science (SC) supports and oversees research facilities and pro- grams that cover basic science through its application to the demonstration and deployment of energy technologies. SC oversees 10 of the 17 DOE National Labs and 28 major federal research user facilities. Its mission is to preserve U.S. leader- ship in science, fund and perform basic research, and provide the scientific facilities that the private sector is unable or unwilling to provide. New initiatives include quantum information sciences and artificial intelligence. SC is led by a Senate-con- firmed Director at the Assistant Secretary level and has eight program offices.82 Needed Reforms The next conservative President should commit the United States to scientific dominance to support national and economic security, especially in light of similar efforts by China. To aid in this effort, the Office of Science should: l Return to its primary mission: nonpartisan and basic science. SC’s mission should be international leadership in basic and early applied science and provision of world-leading facilities for this work. The Infrastructure Investment and Jobs Act and Inflation Reduction Act mark the major — 394 — Mandate for Leadership: The Conservative Promise reorientation of DOE primarily from defense applications in the NNSA and basic and early applied science across SC and the applied offices to a massive federal research, development, demonstration, and commercialization body.83 Distraction from SC’s basic science mission should be prevented. l Increase the level of accountability. The National Laboratories need to be more directly accountable to the Secretary of Energy and Congress for their work and management. New Policies l Commit to U.S. science dominance. The United States is losing its dominance in scientific discoveries and technological development. China and other adversaries have been stealing American science and technology for years and are now on the verge of dominating science—a development that is fraught with negative strategic and economic implications for the United States. The next Administration must commit itself to ensuring that the U.S. continues to dominate scientific discovery and technological advancement. l Refocus on mission and eliminate duplication and waste. The Administration should work with Congress to rationalize the National Lab network to meet specific national objectives (such as the NNSA laboratories’ role in national defense) and conduct basic research that the private sector would not otherwise conduct. Activities that duplicate those of other government agencies or the private sector should be eliminated. l Properly manage the National Labs’ contributions to the private sector. SC should improve private-sector access to the National Labs, through programs like the GAIN voucher program and consistent with national security considerations, while ensuring that the economic benefits of taxpayer-funded technologies flow back to taxpayers through patent- review sharing or a revolving fund. Budget The Office of Science was appropriated slightly more than $7 billion in FY 2021, and DOE requested slightly less than $7.8 billion for FY 2023.84 OFFICE OF ENVIRONMENTAL MANAGEMENT (EM) Mission/Overview The Office of Environmental Management’s mission is to “complete the safe cleanup of [the] environmental legacy resulting from decades of nuclear
Showing 3 of 5 policy matches
About These Correlations
Policy matches are calculated using a hybrid approach: initial candidates are found using semantic similarity between bill summaries and Project 2025 policy text, then an AI model (Llama 3.1 70B) provides detailed alignment ratings and analysis. Ratings range from 1 (minimal alignment) to 5 (very strong alignment). This analysis does not imply direct causation or intent.